Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies

Cited by (481)

Items 101–200 of 481

1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
   Diego Francesco Calvisi, Luke Boulter, Javier Vaquero, Anna Lena Saborowski, Luca Fabris, Pedro Miguel Rodrigues, Cédric Coulouarn, Rui Eduardo Castro, Oreste Segatto, Chiara Raggi et al. · 2023 · Nature Reviews Gastroenterology & Hepatology
2. Precision models in hepatocellular carcinoma
   Marina Bárcena‐Varela, Satdarshan P. Monga, Amaia Lujambio · 2024 · Nature Reviews Gastroenterology & Hepatology
3. Cholangiocarcinoma 2020: the next horizon in mechanisms and management
   Banales, Jesus M., Marin, Jose J. G., Lamarca, Angela, Rodrigues, Pedro M., Khan, Shahid A., Roberts, Lewis R., Cardinale, Vincenzo, Carpino, Guido, Andersen, Jesper B., Braconi, Chiara et al. · 2020 · Nature Reviews Gastroenterology & Hepatology
4. Advances in the application of 3D tumor models in precision oncology and drug screening
   Xiaoyong Guan, Shigao Huang · 2022 · Frontiers in Bioengineering and Biotechnology
5. Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
   Ji Wang, Chao Chen, Lu Wang, Mingjun Xie, Xinyang Ge, Sufan Wu, Yong He, Xiaozhou Mou, Chenyang Ye, Yi Sun · 2022 · Frontiers in Oncology
6. 3D culture models to study pathophysiology of steatotic liver disease
   Andrea Marco Caddeo, Samantha Maurotti, Lohitesh Kovooru, Stefano Romeo · 2024 · Atherosclerosis
7. Models for Understanding Resistance to Chemotherapy in Liver Cancer
   José J.G. Marı́n, Elisa Herráez, Elisa Lozano, Rocı́o I.R. Macı́as, Óscar Briz · 2019 · Cancers
8. Recreating Tumour Complexity in a Dish: Organoid Models to Study Liver Cancer Cells and their Extracellular Environment
   Gilles S. van Tienderen, Bas Groot Koerkamp, Jan N.M. IJzermans, Luc J. W. van der Laan, Monique M. A. Verstegen · 2019 · Cancers
9. Human-correlated genetic models identify precision therapy for liver cancer
   Miryam Müller, Stephanie May, Holly Hall, Timothy James Kendall, Lynn McGarry, Lauriane Blukacz, Sandro Nuciforo, Αναστασία Γεωργακοπούλου, Thomas Jamieson, Narisa Phinichkusolchit et al. · 2025 · Nature
10. In Vitro Models of the Liver: Disease Modeling, Drug Discovery and Clinical Applications
    Scott D. Collins, Gloria Yuen, Thomas Tu, Magdalena A. Budzinska, Kevin J. Spring, Katherine Bryant, Nicholas Adam Shackel · 2019 · Codon Publications eBooks
11. In vitro functional models for human liver diseases and drug screening: beyond animal testing
    Paradiso, Alessia, Volpi, Marina, Rinoldi, Chiara, Celikkin, Nehar, Contessi Negrini, Nicola, Bilgen, Muge, Dallera, Giorgio, Pierini, Filippo, Costantini, Marco, Święszkowski, Wojciech et al. · 2023 · Biomaterials Science
12. Identification of SPP1+ macrophages in promoting cancer stemness via vitronectin and CCL15 signals crosstalk in liver cancer
    Yizhou Wang, Qing Wang, Shuangfen Tao, Haoyu Li, Xiaofeng Zhang, Yong Xia, Yue Wang, Cheng Zhi Yang, Chengjun Sui · 2024 · Cancer Letters
13. Cholangiocyte organoids from human bile retain a local phenotype and can repopulate bile ducts in vitro
    Roos, Floris J. M., Wu, Haoyu, Willemse, Jorke, Lieshout, Ruby, Albarinos, Laura A. Muñoz, Kan, Yik‐Yang, Poley, Jan‐Werner, Bruno, Marco J., de Jonge, Jeroen, Bártfai, Richard et al. · 2021 · Clinical and Translational Medicine
14. Lung cancer organoids, a promising model still with long way to go
    Haochuan Ma, Yan-juan Zhu, Rui Zhou, Yaya Yu, Zhenzhen Xiao, Hai-bo Zhang · 2022 · Critical Reviews in Oncology/Hematology
15. Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
    Hee Seung Lee, Dai Hoon Han, Kyungjoo Cho, Soo Been Park, Chanyang Kim, Galam Leem, Dawoon Jung, Soon Sung Kwon, Chul Hoon Kim, Jung Hyun Jo et al. · 2023 · Nature Communications
16. Liver Cancer: Current and Future Trends Using Biomaterials
    Sue Anne Chew, Stefania Moscato, Sachin George, Bahareh Azimi, Serena Danti · 2019 · Cancers
17. Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model
    Xuelu Li, Bo Pan, Xiaoqing Song, Ning Li, Dongyi Zhao, Man Li, Zuowei Zhao · 2020 · Cancer Cell International
18. Examining the gut-liver axis in liver cancer using organoid models
    Dmitrii Shek, Dishen Chen, Scott A. Read, Golo Ahlenstiel · 2021 · Cancer Letters
19. Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities
    Jiani Yang, Shan Huang, Shanshan Cheng, Yue Jin, Nan Zhang, Yu Wang · 2021 · Frontiers in Cell and Developmental Biology
20. Liver organoids: established tools for disease modeling and drug development
    Sun, Xi-Cheng, Kong, De-fu, Zhao, Jie, Faber, Klaas Nico, Xia, Qiang, He, Kang · 2023 · Hepatology Communications
21. Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model
    Kevin L. Zhou, Xiaoqi Huo, Romario Nguyen, Sarah Da Won Bae, Shuanglin Han, Zhiqiang Zhang, Wei Duan, Lawrence Yuen, Vincent W. T. Lam, Jacob George et al. · 2021 · Journal of Controlled Release
22. Patient-derived Tumour Organoids: A Bridge between Cancer Biology and Personalised Therapy
    Wence Wu, Xiaoyang Li, Shengji Yu · 2022 · Acta Biomaterialia
23. MAIT cells in liver inflammation and fibrosis
    Hema Mehta, Martin Joseph Lett, Paul Klenerman, Magdalena Filipowicz Sinnreich · 2022 · Seminars in Immunopathology
24. Culture of patient-derived multicellular clusters in suspended hydrogel capsules for pre-clinical personalized drug screening
    Haijiang Dong, Zequn Li, Suchen Bian, Guangyuan Song, Wenfeng Song, Mingqi Zhang, Haiyang Xie, Shusen Zheng, Xuxu Yang, Tiefeng Li et al. · 2022 · Bioactive Materials
25. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review
    Qi Wang, Juan Liu, Ziye Chen, Jingjing Zheng, Yunfang Wang, Jiahong Dong · 2023 · Biomedicine & Pharmacotherapy
26. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma
    Silvestre Vicent, Ruby Lieshout, Anna Lena Saborowski, Monique M. A. Verstegen, Chiara Raggi, Stefania Recalcati, Pietro Invernizzi, Luc J. W. van der Laan, Domenico Alvaro, Diego Francesco Calvisi et al. · 2019 · Liver International
27. Gene manipulation in liver ductal organoids by optimized recombinant adeno-associated virus vectors
    Jinsong Wei, Gai Ran, Xin Wang, Ning Jiang, Jianqing Liang, Xinhua Lin, Chen Ling, Bing Tian Zhao · 2019 · Journal of Biological Chemistry
28. Hepatocellular Carcinoma
    Rodrigo Carlessi, Julia Köhn‐Gaone, John Kevin Olynyk, Janina E. E. Tirnitz‐Parker · 2019 · Codon Publications eBooks
29. Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective
    Danijel A. Galun, Dragana Danilo Mijac, Aleksandar Filipović, Aleksandar Bogdanović, Marko Zivanovic, Dragan Mašulović · 2022 · Journal of Personalized Medicine
30. Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors
    Tanja Blumer, Isabel Fofana, Matthias Sebastian Matter, Xueya Wang, Hesam Montazeri, Diego Calabrese, Mairene Coto‐Llerena, Tuyana Boldanova, Sandro Nuciforo, Venkatesh Kancherla et al. · 2019 · Hepatology Communications
31. Organoids: Past Learning and Future Directions
    Lauren O’Connell, Des C. Winter · 2019 · Stem Cells and Development
32. Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids
    Zhiwei Wang, Yinghao Guo, Yun Jin, Xiaoxiao Zhang, Hao Geng, Guangyuan Xie, Dan Ye, Yuanquan Yu, Daren Liu, Donger Zhou et al. · 2021 · Cancer Cell International
33. Hepatobiliary tumor organoids for personalized medicine: a multicenter view on establishment, limitations, and future directions
    Gilles S. van Tienderen, Ling Li, Laura Broutier, Yoshimasa Saito, Patrícia Inácio, Meritxell Huch, Florin M. Selaru, Luc J. W. van der Laan, Monique M. A. Verstegen · 2022 · Cancer Cell
34. A co-culture system of macrophages with breast cancer tumoroids to study cell interactions and therapeutic responses
    Antonella Raffo‐Romero, Lydia Ziane-Chaouche, Sophie Salomé‐Desnoulez, Nawale Hajjaji, Isabelle Fournier, Michel Salzet, Marie Duhamel · 2024 · Cell Reports Methods
35. Organoids in cancer research: a review for pathologist‐scientists
    Laura DeLong Wood, Andrew J. Ewald · 2021 · The Journal of Pathology
36. 3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis
    Shringar Rao, Tanvir Hossain, Tokameh Mahmoudi · 2021 · Cancer Letters
37. Emerging liver organoid platforms and technologies
    Do Thuy Uyen Ha Lam, Yock Young Dan, Yun-Shen Chan, Huck‐Hui Ng · 2021 · Cell Regeneration
38. Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients
    Khamushavalli Geevimaan, Jing-You Guo, Chia‐Ning Shen, Jeng‐Kai Jiang, Cathy S.J. Fann, Ming‐Jing Hwang, Jr‐Wen Shui, Hsiu-Ting Lin, Mei-jung Sebrina Wang, Hsuan-Cheng Shih et al. · 2022 · Frontiers in Oncology
39. Liver organoids: an in vitro 3D model for liver cancer study
    Renshun Dong, Bixiang Zhang, Xuewu Zhang · 2022 · Cell & Bioscience
40. Transcription factors TEAD2 and E2A globally repress acetyl-CoA synthesis to promote tumorigenesis
    Sujin Park, Dirk Mossmann, Qian Chen, Xueya Wang, Eva Dazert, Marco Colombi, Alexander Schmidt, Brendan M Ryback, Charlotte K.Y. Ng, Luigi Terracciano et al. · 2022 · Molecular Cell
41. Mapping oncogenic protein interactions for precision medicine
    Mehdi Sharifi Tabar, Habib Francis, Dannel Yeo, Charles G. Bailey, John E.J. Rasko · 2022 · International Journal of Cancer
42. A decade of liver organoids: Advances in disease modeling
    Liu, Yue, Sheng, Jian-Ying, Yang, Chun-Fang, Ding, Junjun, Chan, Yun-Shen · 2023 · Clinical and Molecular Hepatology
43. Drug Screening, Oral Bioavailability and Regulatory Aspects: A Need for Human Organoids
    Tamara Zietek, Wolfgang Boomgaarden, Eva Rath · 2021 · Pharmaceutics
44. Application of medical imaging methods and artificial intelligence in tissue engineering and organ-on-a-chip
    Wanying Gao, Chunyan Wang, Qiwei Li, Xijing Zhang, Jianmin Yuan, Dianfu Li, Yu Sun, Zaozao Chen, Zhongze Gu · 2022 · Frontiers in Bioengineering and Biotechnology
45. Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells
    Maria Kopsida, Ada Lerma Clavero, Jaafar Khaled, David Balgoma, Clara Luna-Marco, Azazul Islam Chowdhury, Sofi Sennefelt Nyman, Fredrik Rorsman, Charlotte Ebeling Barbier, Peter Bergsten et al. · 2023 · Molecular Metabolism
46. Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models
    Qingfan Zheng, Bin Zhang, Changfeng Li, Xuewen Zhang · 2022 · Frontiers in Oncology
47. Toward reproducible tumor organoid culture: focusing on primary liver cancer
    Lianming Guo, Chao Li, Weiqiang Gong · 2024 · Frontiers in Immunology
48. Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges
    Antonio Cigliano, Weiting Liao, Giovanni Andrea Deiana, Davide Rizzo, Xin Chen, Diego Francesco Calvisi · 2024 · Biomedicines
49. Automated detection and growth tracking of 3D bio-printed organoid clusters using optical coherence tomography with deep convolutional neural networks
    Di Bao, Ling Wang, Xiaofei Zhou, Shanshan Yang, Kangxin He, Mingen Xu · 2023 · Frontiers in Bioengineering and Biotechnology
50. A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine
    Jessica Kalla, Janette Pfneissl, Theresia Mair, Loan Tran, Gerda Egger · 2024 · Cellular Oncology
51. Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety.
    Gerardo Botti, Maurizio Di Bonito, Monica Cantile · 2021 · PubMed Central
52. Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives
    Koji Miyabayashi, Hayato Nakagawa, Kazuhiko Koike · 2021 · Frontiers in Oncology
53. Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses
    Qian Chen, Mairene Coto‐Llerena, Aleksei Suslov, Raphael Dias Teixeira, Isabel Fofana, Sandro Nuciforo, Maike Hofmann, Robert Thimme, Nina Hensel, Volker Lohmann et al. · 2021 · Nature Communications
54. Liver Organoids as an In Vitro Model to Study Primary Liver Cancer
    Silvia De Siervi, Cristian Turato · 2023 · International Journal of Molecular Sciences
55. State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment
    Julien Giron‐Michel, Maël Padelli, Estelle Oberlin, Hind Guénou, Jean‐Charles Duclos‐Vallée · 2025 · BioDrugs
56. Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers
    Romario Nguyen, Sarah Da Won Bae, Gang Zhou, Scott A. Read, Golo Ahlenstiel, Jacob George, Liang Qiao · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
57. The promise of human organoids in the digestive system
    Masaaki Funata, Yasunori Nio, Derek M. Erion, Wendy L. Thompson, Takanori Takebe · 2020 · Cell Death and Differentiation
58. Tumor organoids for cancer research and personalized medicine
    Hui Yang, Yinuo Wang, Peng Wang, Ning Zhang, Pengyuan Wang · 2021 · Cancer Biology and Medicine
59. Emerging trends in modeling human liver disease in vitro
    Gregory H. Underhill, Salman R. Khetani · 2019 · APL Bioengineering
60. Epigenetic Regulation of Cell-Fate Changes That Determine Adult Liver Regeneration After Injury
    Luigi Aloia · 2021 · Frontiers in Cell and Developmental Biology
61. Liver Organoids: Updates on Disease Modeling and Biomedical Applications
    Carmen Caiazza, Silvia Parisi, Massimiliano Caiazzo · 2021 · Biology
62. The pivotal application of patient-derived organoid biobanks for personalized treatment of gastrointestinal cancers
    Yaya Yu, Yan-juan Zhu, Zhenzhen Xiao, Yadong Chen, Xuesong Chang, Yi‐Hong Liu, Qing Tang, Haibo Zhang · 2022 · Biomarker Research
63. Tumor Organoid and Spheroid Models for Cervical Cancer
    Ivana Kutle, Robert Polten, Jens Hachenberg, Rüdiger Klapdor, Michael Alexander Morgan, Axel Schambach · 2023 · Cancers
64. Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineering
    Hang Sun, Huayu Yang, Yilei Mao · 2023 · Frontiers in Pharmacology
65. Liver organoids: updates on generation strategies and biomedical applications
    Sen Liu, Chuanliang Cheng, Liuyang Zhu, Tianyu Zhao, Ze Wang, Xiulin Yi, Fengying Yan, Xiaoliang Wang, Chunli Li, Tao Cui et al. · 2024 · Stem Cell Research & Therapy
66. Organoids and spheroids: advanced in vitro models for liver cancer research
    Mirella Pastore, Alessia Giachi, Elena Spínola-Lasso, Fabio Marra, Chiara Raggi · 2025 · Frontiers in Cell and Developmental Biology
67. Molecular subtypes of intrahepatic cholangiocarcinoma
    Alessandro De Santis, Lei Zhu, Jianxin Tao, Christoph Reißfelder, Sebastian Schölch · 2025 · Trends in Molecular Medicine
68. The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in Cholangiocarcinoma
    Orawan Suppramote, Sunisa Prasopporn, Satinee Aroonpruksakul, Ben Ponvilawan, Jiradej Makjaroen, Monthira Suntiparpluacha, Krittiya Korphaisarn, Komgrid Charngkaew, Rawisak Chanwat, Trairak Pisitkun et al. · 2022 · Frontiers in Oncology
69. Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
    Marie‐Anne Meier, Sandro Nuciforo, Mairene Coto‐Llerena, John Gallon, Matthias Sebastian Matter, Caner Ercan, Jürg Vosbeck, Luigi Terracciano, Savas Deniz Soysal, Daniel Tobias Boll et al. · 2022 · Communications Medicine
70. Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models
    Sang Woo Lee, Da Jung Jung, Gi Seok Jeong · 2020 · Tissue Engineering and Regenerative Medicine
71. Liver organoids: Current advances and future applications for hepatology
    Kim, Yohan, Kang, Minseok, Mamo, Michael Girma, Adisasmita, Michael, Huch, Meritxell, Choi, Dongho · 2025 · Clinical and Molecular Hepatology
72. VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference
    Stefano Conti Nibali, Silvia De Siervi, Enrico Luchinat, Andrea Magrì, Angela Anna Messina, Lorenza Brocca, Stefania Mantovani, Barbara Oliviero, Mostafa H. Ahmed, Mario Umberto Mondelli et al. · 2024 · iScience
73. Integration of Organoids With CRISPR Screens: A Narrative Review
    Rushikesh Mukhare, Khushboo Gandhi, Anushree Kadam, Aishwarya Raja, Ankita Singh, Mrudula Madhav, Rohan Chaubal, Shwetali Pandey, Sudeep Gupta · 2025 · Biology of the Cell
74. Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives
    Floriana Jessica Di Paola, Giulia Calafato, Pier Paolo Piccaluga, Giovanni Tallini, Kerry Jane Rhoden · 2025 · Journal of Personalized Medicine
75. Investigating virus–host cell interactions: Comparative binding forces between hepatitis C virus-like particles and host cell receptors in 2D and 3D cell culture models
    Simon Collett, Joseph Torresi, Linda Earnest Silveira, Vi Khanh Truong, Dale Christiansen, Bang M. Tran, Elizabeth Vincan, Paul A. Ramsland, Aaron James Elbourne · 2021 · Journal of Colloid and Interface Science
76. In Vitro Veritas: From 2D Cultures to Organ-on-a-Chip Models to Study Immunogenic Cell Death in the Tumor Microenvironment
    Dmitri V. Krysko, Robin Demuynck, Iuliia Efimova, Faye Naessens, Olga Krysko, Elena Catanzaro · 2022 · Cells
77. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer
    Yukun Chen, Yujun Liu, Shimin Chen, Long Zhang, Jiawei Rao, Xinjun Lu, Yi Ma · 2023 · Frontiers in Immunology
78. Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions
    Yanjing Zhu, Shijie Tang, Qiuyue Yuan, Jing Fu, Juan He, Zhuang Liu, Xiaofang Zhao, Yunguang Li, Yan Zhao, Yani Zhang et al. · 2024 · Cell Reports Medicine
79. Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models
    Jack Leslie, Kishore Alagere Krishnamurthy, Indresh K Gopalsamy, Patrícia Inácio, Meritxell Huch, Suchira Gallage, Fiona Oakley, Michele Vacca · 2026 · Nature Reviews Gastroenterology & Hepatology
80. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform
    Bo Pan, Dongyi Zhao, Yaqian Liu, Na Li, Chen Song, Ning Li, Xuelu Li, Zuowei Zhao · 2021 · In Vitro Cellular & Developmental Biology - Animal
81. Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma
    Christos M. Dimitrakopoulos, Sravanth Kumar Hindupur, Marco Colombi, Dritan Liko, Charlotte K.Y. Ng, Salvatore Piscuoglio, Jonas Behr, Ariane L. Moore, Jochen Singer, Hans‐Joachim Ruscheweyh et al. · 2021 · BMC Genomics
82. Preclinical mouse models of hepatocellular carcinoma: An overview and update
    Catherine Yujia Gu, Terence K. Lee · 2022 · Experimental Cell Research
83. Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma
    Mairene Coto‐Llerena, Andrej Benjak, John Gallon, Marie-Anne Meier, Tuyana Boldanova, Luigi M. Terracciano, Charlotte K.Y. Ng, Salvatore Piscuoglio · 2022 · JCO Precision Oncology
84. Establishment and characterization of canine mammary tumoroids for translational research
    Antonella Raffo‐Romero, Soulaimane Aboulouard, Emmanuel Bouchaert, Agata Marta Rybicka, Dominique Tierny, Nawale Hajjaji, Isabelle Fournier, Michel Salzet, Marie Duhamel · 2023 · BMC Biology
85. Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids
    Francesco Amato, Colin J. Rae, Maria Giuseppina Prete, Chiara Braconi · 2020 · Cells
86. The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active
    Celia Sequera, Margherita Grattarola, Floriane Cannet, Aurélie Dobric, Paula Michea Veloso, Melissa Methia, Sylvie Richelme, Abdessamad El Kaoutari, Paraskevi Kousteridou, Delphine Debayle et al. · 2025 · Nature Communications
87. WNT–β-catenin signalling in hepatocellular carcinoma: from bench to clinical trials
    Brandon M. Lehrich, Satdarshan P. Monga · 2025 · Nature Reviews Gastroenterology & Hepatology
88. Thermal management in a biological tissue in order to destroy tissue under local heating process
    Pouya Barnoon, Farnoush Bakhshandehfard · 2021 · Case Studies in Thermal Engineering
89. Tumor Organoid Model and Its Pharmacological Applications in Tumorigenesis Prevention
    Xiaolei Cao, Wenjie Zheng, Yuwei Qiang, Ninghua Yao, Fan Zuo, Shi Qiu · 2022 · Current Molecular Pharmacology
90. Brain Organoids: A Promising Living Biobank Resource for Neuroscience Research
    Shuang Li, Min Wang, Junmei Zhou · 2020 · Biopreservation and Biobanking
91. Mouse Models of Oncoimmunology in Hepatocellular Carcinoma
    Erin R. Bresnahan, Katherine E. Lindblad, Marina Ruiz de Galarreta, Amaia Lujambio · 2020 · Clinical Cancer Research
92. Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinoma
    Ling Li, Gilad Halpert, Michael G. Lerner, Hai‐Jie Hu, Peter Michael Dimitrion, Matthew John Weiss, Jin Peng He, Benjamin Philosophe, Richard Andrew Burkhart, William Reece Burns et al. · 2021 · JCI Insight
93. Advances and Applications of Cancer Organoids in Drug Screening and Personalized Medicine
    Yujia Yang, Yajie Kong, Jinlei Cui, Yu Hou, Zhanjing Gu, Cuiqing Ma · 2024 · Stem Cell Reviews and Reports
94. Microdissection tools to generate organoids for modeling the tumor immune microenvironment
    Seth C. Cordts, Kanako Yuki, Maria Fernanda Henao Echeverri, Balasubramanian Narasimhan, Calvin Jay Kuo, Sindy K. Y. Tang · 2024 · Microsystems & Nanoengineering
95. Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment
    Jianhua Rao, Chao Song, Yangyang Hao, Zaozao Chen, Sidu Feng, Shihui Xu, Xiaoyue Wu, Zhengfeng Xuan, Ye Fan, Wenzhu Li et al. · 2024 · International Journal of Biological Sciences
96. Advances in liver and pancreas organoids: how far we have come and where we go next
    Aleksandra Sljukic, Joshua Green Jenkinson, Armin Niksic, Nicole Prior, Meritxell Huch · 2025 · Nature Reviews Gastroenterology & Hepatology
97. Organoids for the Study of Liver Cancer
    Haichuan Wang, Diego Francesco Calvisi, Xin Chen · 2021 · Seminars in Liver Disease
98. Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase
    Yinghui Wang, Hui Juan Lu, Linchong Sun, Xin Chen, Haoran Wei, Caixia Suo, Junru Feng, Mengqiu Yuan, Shengqi Shen, Weidong Jia et al. · 2021 · Cell Death and Disease
99. Liver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury
    Chiyu He, Di Lu, Zuyuan Lin, Hao Hui Chen, Huigang Li, Xinyu Yang, Modan Yang, Kai Wang, Xuyong Wei, Shusen Zheng et al. · 2022 · Stem Cell Reviews and Reports
100. Toward better drug development: Three-dimensional bioprinting in toxicological research
     Diána Szűcs, Zsolt Fekete, Melinda Guba, Lajos Vince Kemény, Katalin Jemnitz, Emese Kis, Zoltán Veréb · 2023 · International Journal of Bioprinting